The real strategic value of AI in clinical trials is where it operates.
AI that runs alongside the trial is a feature. AI that runs inside the work as it happens is a different kind of asset entirely.
Florence has spent a decade operating inside the workflows where clinical trials actually happen. We’ve seen where startup slows, where handoffs fail, where documents stall, and where operational friction accumulates. That workflow participation is the foundation of Florence AI.
Florence AI turns workflow activity into operational intelligence, helping sponsors, CROs, and sites identify bottlenecks earlier, reduce rework, and improve execution across the trial lifecycle.
How Florence turns workflow activity into operational intelligence.
The AI advantage is no longer the AI itself. Every vendor can access models. Very few participate in the workflows where clinical research actually happens. The difference between those who unlock growth with AI vs. those who just use it to improve basic functionality is where AI gets applied, how it integrates with the work, and whether operators can trust what it surfaces.

